The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study

Overview of attention for article published in Frontiers in Medicine, May 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 22 Mendeley

So far, Altmetric has seen 1 X post from an account with 3,052 followers.

New Research: The Efficacy and Safety of Pirfenidone Combined With Immunosuppressant Therapy in Connective Tissue Disease-Associated Interstitial Lung Disease: A 24-Week Prospective Controlled Cohort Study: Objective … https://t.co/6Mw2m7XF1U #medicalcare

15 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.